|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.00 EUR | +1.85% |
|
+1.25% | -22.86% |
| 05-16 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
| Market Cap | 1.2B 1.05B 969M 899M 1.71B 115B 1.73B 11.6B 4.51B 56.23B 4.51B 4.41B 195B | P/E 2026 * |
13.9x | P/E 2027 * | 9.93x |
|---|---|---|---|---|---|
| Enterprise Value | 1.95B 1.71B 1.57B 1.46B 2.78B 186B 2.81B 18.85B 7.33B 91.39B 7.33B 7.17B 317B | EV / Sales 2026 * |
2.23x | EV / Sales 2027 * | 1.73x |
| Free-Float |
77.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Collegium Pharmaceutical, Inc.
| 1 week | +1.25% | ||
| Current month | +2.53% | ||
| 1 month | +21.80% | ||
| 3 months | +15.63% | ||
| 6 months | -16.49% | ||
| Current year | -22.86% |
| 1 week | 31.2 |  | 33.2 |
| 1 month | 26.4 | | 33.2 |
| 3 years | 18.9 | | 42.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikram Karnani
CEO | Chief Executive Officer | 51 | 12/11/2024 |
Colleen Tupper
DFI | Director of Finance/CFO | 50 | 24/05/2021 |
Thomas Smith
CTO | Chief Tech/Sci/R&D Officer | 65 | 23/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gino Santini
CHM | Chairman | 69 | 15/05/2025 |
John Freund
BRD | Director/Board Member | 72 | 01/02/2014 |
Garen Bohlin
BRD | Director/Board Member | 78 | 01/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.85% | +1.25% | +25.58% | +65.31% | 1.2B | |
| -1.14% | -2.43% | +55.27% | +159.07% | 1,082B | |
| -1.41% | +0.32% | +67.02% | +60.48% | 633B | |
| -2.42% | +0.18% | +35.78% | +85.62% | 461B | |
| -2.79% | +1.37% | +31.00% | +23.05% | 338B | |
| -2.46% | -1.52% | +36.42% | +32.77% | 299B | |
| -2.20% | -0.93% | +27.50% | +40.62% | 291B | |
| -1.77% | +0.99% | -28.85% | -41.41% | 222B | |
| -2.06% | +1.63% | +25.09% | +64.34% | 202B | |
| -1.26% | +2.60% | +15.95% | +70.00% | 163B | |
| Average | -1.79% | +4.45% | +29.08% | +55.99% | 410.27B | |
| Weighted average by Cap. | -1.62% | +5.43% | +40.47% | +79.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 875M 766M 705M 655M 1.24B 83.42B 1.26B 8.44B 3.29B 40.95B 3.28B 3.21B 142B | 886M 776M 715M 663M 1.26B 84.5B 1.28B 8.55B 3.33B 41.48B 3.33B 3.25B 144B |
| Net income | 108M 94.78M 87.3M 81.03M 154M 10.32B 156M 1.05B 407M 5.07B 406M 398M 17.57B | 158M 139M 128M 119M 225M 15.1B 228M 1.53B 595M 7.41B 594M 581M 25.7B |
| Net Debt | 751M 658M 606M 562M 1.07B 71.62B 1.08B 7.25B 2.82B 35.16B 2.82B 2.76B 122B | 328M 287M 264M 245M 466M 31.26B 472M 3.16B 1.23B 15.34B 1.23B 1.2B 53.2B |
| Date | Price | Change |
|---|---|---|
| 07/07/26 | €33.00 | +1.85% |
| 03/07/26 | €32.40 | 0.00% |
| 02/07/26 | €32.40 | +2.53% |
| 01/07/26 | €31.60 | 0.00% |
| 30/06/26 | €31.60 | +0.64% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COLL Stock
- 354 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
